Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross Sectional, Diagnostic Accuracy Study to Validate the Use of a New Device(Inflammacheck™) in Diagnosing COPD by Measuring the Level of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2)

NCT04024657 is registered in ClinicalTrials.gov with Portsmouth Hospitals NHS Trust as lead sponsor.

NCT NCT04024657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04024657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross Sectional, Diagnostic Accuracy Study to Validate the Use of a New Device(Inflammacheck™) in Diagnosing COPD by Measuring the Level of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2)
Lead sponsor
Portsmouth Hospitals NHS Trust
Phase
Observational
Overall status
Completed
Start date
December 17, 2018
Completion date
December 31, 2019
Enrollment
313 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation